Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for diabetes management, has transformed weight loss treatment by suppressing appetite and slowing gastric emptying. Starting doses are deliberately low—typically 0.25 mg weekly—because the medication works best when the body adapts gradually to its effects. PlexusDx offers personalized semaglutide dosing protocols through licensed 503A compounding pharmacies, allowing patients across all 50 states to access treatment without insurance requirements.
Understanding Semaglutide Dose Escalation Schedules
Semaglutide treatment follows a standardized four-week dose progression known as a titration schedule. Week one begins at 0.25 mg, increasing to 0.5 mg in week two, 1.0 mg in week three, and 1.7 mg by week four. This gradual escalation reduces nausea, vomiting, and other gastrointestinal side effects that occur when patients jump to higher doses too quickly. Clinical trials show that patients who follow structured titration schedules demonstrate better long-term adherence and more consistent weight loss outcomes compared to those starting at higher initial doses.
Once patients complete the initial four-week titration phase, they typically remain at their maintenance dose for ongoing therapy. Most individuals see meaningful weight loss results at doses between 1.7 mg and 2.4 mg weekly, though some patients require dosing up to 2.4 mg for optimal response. The pace of dose increases can be adjusted based on how well an individual tolerates the medication—if side effects become bothersome, the escalation timeline can be extended or paused at any step.
How Starting Doses Compare to Maintenance Doses
The initial 0.25 mg starting dose is substantially lower than the 2.4 mg maintenance doses many patients eventually reach, but this difference exists for a specific physiological reason. Your body needs time to develop tolerance to GLP-1 receptor activation, and jumping directly to higher doses overwhelms your system with appetite suppression and delayed stomach emptying. Starting low also allows clinicians to identify whether a patient experiences adverse reactions before committing to higher doses that would cause more pronounced side effects.
Maintenance doses typically range from 1.7 mg to 2.4 mg weekly for weight loss purposes, which differs from the 0.5–1.0 mg range used in type 2 diabetes treatment. This higher dosing requirement exists because weight loss therapy targets different metabolic pathways than glucose control, requiring greater GLP-1 receptor engagement. PlexusDx structures compounded semaglutide offerings so your dose may increase based on individual response—and your monthly price remains unchanged regardless of dose level.
Individual Response Variations in Dose Requirements
Not every patient achieves significant weight loss at the same dose, and genetic factors play a meaningful role in determining optimal dosing. The Precision Peptide Genetic Test offered by PlexusDx evaluates key variants in the GLP1R gene (rs6923761) and other peptide-pathway markers to predict how your body will respond to semaglutide at different dose levels. Patients with certain genetic predispositions may see substantial results at 1.7 mg, while others may require progression to 2.4 mg or need additional time at intermediate doses for appetite suppression to take full effect.
Body composition, metabolic baseline, and concurrent medications all influence how aggressively dosing should increase for each individual. Some patients experience excellent weight loss and appetite control at 1.0 mg and choose to remain at that dose rather than advancing further. Others plateau at intermediate doses and require moving to 2.4 mg to continue losing weight. PlexusDx providers work with patients to determine the most effective dose based on personal tolerance, weight loss progress, and side effect profiles rather than following a one-size-fits-all protocol.
Accessing Compounded Semaglutide at Fixed Monthly Cost
PlexusDx partners with licensed 503A compounding pharmacies across all 50 states to provide semaglutide injections starting at $149 per month, with no insurance requirement or membership fees. This flat-rate pricing structure means that if your dose increases from 0.5 mg to 2.4 mg during your treatment journey, your monthly cost remains identical. The approach removes financial barriers that often prevent patients from achieving clinically appropriate dosing, since concern about escalating costs no longer factors into dose adjustment decisions.
All medications from PlexusDx are compounded specifically for each patient by licensed 503A pharmacies—never 503B facilities—ensuring quality control and customization. Treatment is HSA and FSA eligible, which further improves affordability for patients with tax-advantaged health savings accounts. For patients interested in genetic insights into their peptide pathway responsiveness, the Precision Peptide Genetic Test ($99 add-on after the first month) identifies genetic variants that inform optimal dosing strategies and medication selection.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected subcutaneously once weekly. This low initial dose allows your body to adapt to GLP-1 receptor activation and reduces the likelihood of nausea or vomiting. Doses increase by 0.25 mg each week for four weeks until reaching a maintenance dose, which is typically 1.7–2.4 mg weekly for weight loss therapy.
How long does it take to reach a full maintenance dose?
Standard titration schedules progress from 0.25 mg to full maintenance doses over four weeks, though this timeline can be extended if side effects develop. Some patients may benefit from remaining at intermediate doses (0.5 mg, 1.0 mg, or 1.7 mg) longer than the standard four-week protocol. Your PlexusDx provider can customize the escalation pace based on your individual tolerance and weight loss response.
Does my monthly cost change if my semaglutide dose increases?
No. PlexusDx's pricing model ensures your monthly cost stays flat regardless of dose adjustments—whether you're at 0.25 mg or 2.4 mg, your price remains the same. Compounded semaglutide injections start at $149 per month, removing financial obstacles to achieving the right dose for your metabolism and goals.
Can I stop at a lower dose if it's working well for me?
Yes. Semaglutide dosing is individualized, and many patients achieve meaningful weight loss and appetite control at 1.0 mg or 1.7 mg without advancing to 2.4 mg. If you're experiencing good results and manageable side effects at an intermediate dose, continuing at that level is medically appropriate. The goal is finding the minimum effective dose that works for your body and lifestyle.
How can genetics influence my ideal semaglutide dose?
Your GLP1R gene variant (particularly rs6923761) and other peptide-pathway markers affect how efficiently your body responds to semaglutide at different dose levels. PlexusDx's Precision Peptide Genetic Test ($99) evaluates these variants to predict your likely dose response, helping your provider recommend starting points and escalation strategies tailored to your genetic predispositions rather than guessing at standard protocols.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Ozempic Helpful for PCOS? What You Need to Know
Navigating Your Journey: How to Take Ozempic® Without Getting Sick